Defective Erythrocyte Pyruvate Kinase with Impaired Kinetics and Reduced Optimal Activity
|
|
- Paul Pearson
- 5 years ago
- Views:
Transcription
1 BritishJournal ofhaematology, 1972, 22, 651. Defective Erythrocyte Pyruvate Kinase with Impaired Kinetics and Reduced Optimal Activity DONALD E. PAGLIA, WILLIAM N. VALENTINE AND DONALD L. RUCKNAGEL with the technical assistance of MARY Lu WILSON and JULIE WITTENBERG Departments of Medicine and Pathology, Centerfor the Health Sciences, University of California, Los Angeles; Research and Medical Services, Veterans Administration Center, Los Angeles, Culifornia; and Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan (Received 8 July 1971 ; accepted for publication 19 October 1971) SUMMARY. A unique mutant form of erythrocyte pyruvate kinase has been found associated with chronic haemolytic anaemia in a child who is apparently doubly heterozygous for the mutant isoenzyme and for pyruvate kinase deficiency of the classical quantitative type. Clinical and laboratory findings conformed closely to those typically observed in homozygous pyruvate kinase deficiency anaemia. Assayed in fresh haemolysates, the isoenzyme exlubited reduced optimal activity (c 45% of normal) and an increased Michaelis constant for phosphoenolpyruvate (four to five times greater than normal). The kinetic anomaly was only partially corrected by activation with fructose-i,&&sphosphate. Despite some common characteristics, this isoenzyme appears distinct from others reported in the literature and lends support to the polymorphous nature of heritable haemolytic anaemias secondary to defective pyruvate kinase. Pyruvate kinase (PK) (ATP :pyruvate phosphotransferase, EC ) catalyses the conversion of phosphoenolpyruvate (PEP) and adenosine &phosphate (ADP) to pyruvate and adenosine triphosphate (ATP). This constitutes a critical ATP regenerating reaction in mature human erythrocytes which must rely almost exclusively upon glycolysis to fulfil energy requirements. Homozygously inherited deficiency of the enzyme is often the only definable biochemical lesion in cases of congenital nonspherocytic haemolytic anaemia. No longer entirely tenable, it was the initial presumption that haemolysis occurred in such cases when the quantity of functional enzyme had been degraded to levels incompatible with effective glycolysis. More recent evidence indicates that abnormal isoenzymes of PK also exist which may be associated with haemolytic anaemia despite being highly active in vitro under optimal assay conditions. One such isoenzyme demonstrated markedly impaired kinetics with an elevated Michaelis-Menten constant (K,,,) for one of its substrates, PEP (Paglia et al, 1968). It was postulated that this mutant enzyme might be as rate limiting in glycolysis as normal PK which was quantitatively deficient, since in both instances intracellular PEP concentrations would have to rise appreciably before effective catalysis could occur. Correspondence: Dr Donald E. Paglia, Department of Pathology, Center for the Health Sciences, University of California, Los Angeles, California 90024, U.S.A. 65 1
2 652 D. E. Paplia, W. N. Valentine and D. L. Rucknagel The present report summarizes clinical, haematologic and biochemical findings in another family which appears to be af licted in a similar, yet clearly distinct manner. The maternal side harbours an abnormal PK isoenzyme of a type not previously reported. Heterozygous PK deficiency of the classical form exists in paternal relatives, including the father. By virtue of simultaneous mheritance of the paternal gene resulting in quantitatively deficient activity and the mutant maternal allele, the proband is presumed to have erythrocytes which contain, in effect, only the mutant isoenzyme. The latter was characterized by low optimal activity (V,,,), elevated K, (PEP), and an unusual response to the PK activator, fructose-1,ddiphosphate (FDP). METHODS Subjects The proband was a 7-yr-old male of English-Irish ancestry who was born at full term following an uncomplicated pregnancy and delivery. Jaundice was apparent immediately, with bilirubin elevated to 6.3 mg/ioo ml, of which 0.9 mg/ioo ml was direct-reacting. Haemoglobin was I I.g g/ 100 ml, and there were 76 nucleated erythrocytes per IOO leucocytes. An exchange transfusion was performed on the first day of life, although no blood group antigen incompatibilities could be demonstrated. The patient remained asymptomatic until the onset ofpallor at the age of 14 mth. At 3 mth of age, Hb was 5.9 g/ioo ml, reticulocytes totalled 11.8%, and there were 6 nucleated erythrocytes per IOO leucocytes. Antiglobulin tests were negative. Autohaemolysis was increased and only partially corrected by glucose. Osmotic fragility studies and screening tests for G6PD, PK, and glutathione reductase deficiencies were also normal. Peripheral blood leucocytes totalled /p1 with a normal differential count, and platelets appeared normal. Infancy and early childhood were characterized by chronic haemolytic anaemia, occasional icterus, and progressive hepatosplenomegaly. Transfusions were required at 2-3 mth intervals when Hb levels fell to c 5 g/ioo ml. Reticulocyte counts were generally elevated to 15-20%. Haemoglobin electrophoresis and alkali denaturation showed % Hb F in the proband and no abnormal haemoglobins in the parents. By the age of 6 yr, the liver and spleen extended 3 cm and 10 cm below their respective costal margins. Height, weight and development remained within normal limits for his age. Because of abdominal discomfort and indications of progressive hypersplenism, splenectomy was performed at the age of 63 yr. A total of 9 1. of packed red cells had been given up to that point. Antiglobulin tests were still negative. The spleen weighed 800 g and was characterized by prominent red pulp with moderate littoral cell hyperplasia and scattered haemosiderin-laden macrophages. In the year following splenectomy, he required no further transfusions. Haemoglobin levels fluctuated between 9.2 and 10.4 g/ioo ml, leucocytes between 6000 and 11 goo/pl, and platelet counts were c 540 ooo/pl. There was no history of anaemia or jaundice in any blood relative, including an older sibling, and there was no evidence of consanguinity. Procedures Venous blood specimens from family members and normal controls were anticoagulated by heparin, refrigerated with ice, and shipped from Ann Arbor, Michigan, to Los Angeles
3 Erythrocyte Pyrrttvate Kinuse - Defect 653 for processing within 48 hr. Five-millilitre aliquots of fresh blood were also precipitated by immediate mixture with 10 m10.6 N perchloric acid for determination of adenine nucleotide and glycolytic intermediate concentrations by the methods of Minakami et a1 (1965). A modification of Krimsky's (1963) method was used to measure z,3-diphosphoglycerate. To prepare cells for enzyme assays, heparinized specimens were mixed with 0.25 vol 5% polyvinylpyrrolidone (Plasdone C, Antara Chemicals, General Aniline and Film Corp., Los Angeles, Calif.) and allowed to stand at room temperature. As erythrocytes settled, the supernate, containing mostly platelets and leucocytes, was aspirated free and preserved. Sedimented erythrocytes were washed once with 5 vol cold isotonic saline and centrifuged at 450 g for 10 min. Packed erythrocytes were drawn into a sterile plastic syringe containing an equal volume of compressed nylon wool (FT-242, scrubbed nylon fibre, Fenwal Laboratories, Morton Grove, Ill.) and warmed in an incubator to 37 C for 30 min, with periodic remixing of the contents by rotation. This allowed most remaining granulocytes to contact and adhere to nylon fibres, yielding red cell preparations minimally contaminated with leucocytes. After incubation, erythrocytes were discharged from the syringe and washed twice with 10 vol cold isotonic saline, and centrifuged at 450 g for 10 min after each wash. Packed cells were diluted with saline to final concentrations of c 3 x 10~1~1. Exact concentrations were determined by quadruplicate measurements with a Coulter Model F Counter, and the number of remaining leucocytes in each red cell preparation was determined by duplicate haemocytometer counts. Leucocytes in the supernate preserved from the initial sedimentation procedure were similarly packed, washed twice with 30 mi cold isotonic saline, and centrifbged as before. Washed leucocytes, now virtually free of platelets but variably contaminated with erythrocytes, were diluted with saline to c 4x 10~1~1. Final counts were determined in quadruplicate with the Coulter Counter. Enzyme assays were performed using fresh cell lysates prepared by dilution in buffered saline or water and thrice frozen and thawed with a Dowanol and solid C02 freezing bath. Assays of glycolytic, pentosephosphate pathway and ancillary enzymes were performed by procedures delineated elsewhere (Koutras et al, 1964; Schneider et al, 1965; Valentine et al, 1967, 1969,1970; Pagfa & Valentine, 1967; Baughan et d, 1968). Pyruvate kinase activity was determined by the method of Bucher & Pfleiderer (1955) as modified in a previous report (Valentine& Tanaka, 1966). The standard assay system employed 2.0 m~ PEP, 0.4 m~ ADP, 8.0 m~ MgSO,, 0.2 m~ reduced nicotine adenine dinucleotide (NADH), 6 units/& lactate dehydrogenase (LDH), and 75 m~ KCI in 8.3 mm triethanolamine hydrochloride buffer at a final ph of An identical system containing only 0.4 m~ PEP was assayed simultaneously. Pyruvate formed from PEP by the PK reaction was immediately converted to lactate by the crystalline LDH with consequent oxidation of NADH. The latter was observed by monitoring the time sequence of absorbence changes at 340 mp using a Gilford multiple sample absorbence recorder, Model Reagent blanks devoid of haemolysate were assayed at each PEP concentration used, and the resultant values (usually almost negligible) were subtracted from activities observed in complete systems. Enzyme units (u) were defined as the number of micromoles of NADH oxidized each minute by 10" cells at 37 C. Apparent PK Michaelis constants for PEP were determined at two different concentrations B
4 654 D. E. Paglia, W. N. Valentine and D. L. Rucknagel of ADP, 0.4 and 1.0 m ~ Phosphoenolpyruvate. concentration was varied between 0.1 and 10.0 m ~ Michaelis. constants for ADP were measured using 2.0 m~ PEP and ADP concentrations between 0.1 and 10.0 m ~ Values. for K,,, were obtained by extrapolation of twelvepoint Wolff plots and confirmed by determination of substrate concentrations coinciding with half maximal activities by direct reading of best-fit linear coordinate curves. RESULTS Haematologic studies Haematologic values obtained on family members during the 9 mth study period are summarized in Table I. The proband was persistently anaemic despite periodic transfusions TABLE I. Mean haematologic measurements on shipped specimens: kindred C Subject Proband (III-z)* Mother (11-3) Father (11-2) Brother (111-1) Paternal aunt (11-1) Maternal uncle (11-4) Maternal grandmother (1-4) Paternal grandmother (1-2) Paternal grandfather (1-1) 1 Hb (&?/I00 ml) PCV (%I I * Genealogy designation according to Fig 6. Reticulocytes (%I I I and consistent reticulocytosis, but anaemia was not apparent in any relative. Low levels of peripheral leucocytes had been a common fmding in this patient for almost 4 yr, and platelet counts were also slightly reduced during this period. The proband's erythrocytes exhibited moderately severe anisopoikilocytosis with frequent schistocytes and pyknocytes. Leucocyte morphology and differential counts were normal. Glycolytic Intermediates and Adenine Nucleotides Peripheral blood concentrations of glycolytic intermediates were measured in the patient and his parents and found to be normal in the latter. In the proband's specimens, however, marked elevations of some intermediates were demonstrable, most prominently the phosphoglycerates, PEP, and hexosemonophosphates, which were three to five times normal mean levels. The pattern of intermediate elevations was remarkably similar to that seen in classical homozygous PK deficiency as shown in Fig I, which demonstrates further that these changes were not simply a consequence of reticulocytosis. Blood ATP concentrations were reduced in the proband, and the ATP/ADP ratio was reversed. Erythrocyte Enzyme Activities Fig 2 presents relative profiles of various enzyme activities in freshly prepared crude
5 Erythrocyte Pyruvate Kinase Ddect 655 haemolysates. Elevated catalytic rates in proband haemolysates correlated well with the activity increases characteristic of specimens with young mean cell ages. The notable excep tion was PK, which approximated 40% of normal mean activities and only 20% of that expected in a specimen with this degree of reticulocytosis. The only abnormality in parental enzyme activities was a similar reduction of PK to 4~60% of normal rates. Activity decrements of this magnitude are generally found in heterozygous PK deficiencies, which are Mother I Ot Father '\;P ' FAP ' GiP ' 3bG ' PLP ' L k ' AbP I F6P DHAP DPG 2PG PYR ATP AMP FIG I. Relative concentrations of peripheral blood glycolytic intermediates and adenine nucleotides. Mean laboratory values for normal subjects are represented by the horizontal line at a multiple of I. Broken curves, labelled 'PK deficiencies' (0) and 'Reticulocytosis' (m) respectively, represent mean values from simultaneous assays of two cases with classical homozygous PK deficiency anaemia and from six cases with a mean reticulocyte count of 8.8% induced by causes other than erythroenzymopathies. Compounds abbreviated along the abscissa are in order: glucose-6-phosphate, fructose-6- phosphate, fructose-r,6-disphosphate, dihydroxyacetone phosphate, glyceraldehyde-3-phosphate, 2,3-diphosphoglycerate, 3-phosphoglycerate, 2-phosphoglycerate, phosphoenolpyruvate, pyruvate, lactate, and adenosine triphosphate, diphosphate and monophosphate. almost always devoid of accelerated haemolysis. By comparison, V,,, in anaemic patients with homozygous deficiency is usually less than 20% of normal mean. Activities at 2.0 mm PEP are a close reflection of PK V,,, for normal erythrocytes under these assay conditions. As shown in Table 11, all members of the immediate family, as well as the paternal grandmother and aunt, had values compatible with heterozygous PK deficiency. Activities were marginal in some relatives, but were interpretable with greater certainty when compared with their accompanying controls. Measurement of PK activities both at low and high substrate concentrations (e.g. 0.4 and -
6 656 D. E. Paglia, W. N. Valentine and D. L. Rucknagel 2.0 m~ PEP) has been found to be a useful screening technique for detection of kinetic abnormalities (Paglia et al, 1968). Ratios of activities at these two concentrations are consistently greater than 0.7 with normal PK and may be reduced below 0.2 for some mutant forms of PK which are incapable of catalysing effectively under conditions of low substrate availability. Applying this index, the proband s activity ratio of 0.50 was found to be distinctly abnormal, as was the maternal value of 0.55, suggesting the presence of anomalous PEP kinetics. Ratios for all other family members were with normal limits. GPI ALD G3PD PGM PK G6PD DPS GP FIG 2. Relative activies of various erythrocyte enzymes. Mean laboratory values for normal subjects are represented by the horizontal line at a multiple of I. The broken curve labelled Reticulocytosis describes mean values derived from 17 cases of haemolytic anaemia exclusive of erythroenzymopathies with a mean reticulocyte count of 11.2%. Enzymes abbreviated along the abscissa are in order: hexokinase, glucosephosphate isomerase, phosphofruaokinase, aldolase, triosephosphate isomerase, glyceraldehyde-pphosphate dehydrogenase, phosphoglycerate kinase, 3-phosphoglyceromutase, enolase (phosphopyruvate hydratase), pyruvate base (assayed at 2.0 m~ PEP and at 0.4 m~ PEP), lactate dehydrogenase, glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, combined enzymes of the distal pentosephosphate pathway, glutathione reductase, glutathione perofidase and glyoxalase. F~uctose-I,6-diphosphate EJect in Standard PK Assay System Significant activation of both proband and control PK activities was apparent over a broad range of FDP concentrations when availability of PEP was suboptimal (Fig 3). The two isoenzymes responded to variable FDP concentrations in a similar manner under these conditions, but the magnitude of response was considerably greater for proband PK. Concentrations greater than I m~ FDP may induce inhibition of PK activity. Consequently, the concentration of 0.1 ~YIM FDP was selected to provide optimal activation of both normal and mutant isoenzymes for comparative purposes. Addition of 0.1 flz~ FDP to the standard assay system slightly enhanced PK activities at 2.0 m~ PEP with disproportionately larger increases evident at 0.4 m~ PEP (Table 11). It
7 TABLE 11. Results of standard assays for PK activities employing 0.4 and 2.0 mm PEP Subject 0.4 mm 2.0 mm PEP PEP Ratio* Erythrocyte PK assays (u) I Leucocyte PK assays (u) I FDP activated I 0.4m~ 2.0m~ 0.4 mm 2.0m~ PEP PEP Ratio PEP PEP Ratio FDP activated 0.4 mm 2.0m~ PEP PEP Ratio Proband (111-2) Mother (11-3) Father (11-2) Brother (111-1) Paternal aunt (It-I) Maternal uncle (11-4) Maternal grandmother (1-4) Paternal grandmother (1-2) Paternal grandfather (1-1) Shipped controls (mean of seven) I O.gO I IISO * Ratio of PK activity at 0.4 mm PEP to that at 2.0 mm PEP
8 65 8 D. E. Paglia, W. N. Vdentine and D. L. Rucknagel was notable, however, that proband and maternal values at the higher substrate concentration were increased approximately 40% by the activator, while increases in all other instances more closely approximated 10%. The overall effect in each case was to alter activity ratios upward toward more clearly normal values. Leucocyte PK determinations are subject to considerably more variation, normals in our laboratory ranging from c 750 u to 2100 u. Values included in Table I1 indicate that proband activities were marginally low, but this did not appear to be a significant deviation and may have been a reflection of contamination of the white cell preparations with nucleated erythrocytes. FDP had no apparent activation effect on PK in white cell lysates from any of the 25c a c.-.? 20c c U Y a f._._ C.A. 0 c c 0 a 15C I oc o IO-~ IO-~ IO-~ IO+ lo-' I 10 FDP concentration (mm) FIG 3. PK activation by varying concentrations of fructose-i,6-&phosphate in haemolysates from the proband and a normal control. To accentuate FDP activation, assays were performed using 2.0 mm ADP and a suboptimal concentration of PEP (0.4 m ~). subjects studied, and addition of FDP to the reaction medium seemed to result in somewhat lessened PK activities. Kinetics of Erythrocyte Pyriivate Kinase Kinetic curves characteristic of PK in proband and parental haemolysates are presented in Fig 4. For comparative purposes, a mean curve derived from accompanying control specimens is included. Usually, rapid increases in reaction rates are observed with only slight elevations in substrate concentration until V,,, is achieved at m~ PEP. In sharp contrast, the proband curve was markedly skewed by a prolonged ascending limb. V,,, was less than half normal mean values and was not reached until PEP concentration was t 5 m. The maternal curve was similar to that of the proband, but activities at corresponding
9 Erythrocyte Pyruvate Kinase Dgect 659 substrate levels were uniformly higher and V,,, may have been achieved somewhat sooner (3-4 mm PEP). Kinetics in paternal haemolysates more closely approximated those of subjects with classical heterozygous PK deficiency. V,,, was slightly over half normal mean, but there was no impairment of activity with substrate deprivation as in the case of the proband and his mother. Kinetic curves were developed for other relatives and their corresponding controls, affording more accurate determinations of V,,, and apparent K, (PEP) in each instance. Table I11 records mean & (PEP) obtained from Wolff plots and confirmed by linear coordinate curves. Michaelis constants were interpretable as normal in all family members r 3- /' -1 /'\.-.-.\. Control PEP concenlrotion (mm) FIG 4. PK kinetic curves with PEP as the variable substrate. Arrows indicate points of half maximal PK activities which correspond to K, (PEP) values on the abscissa. except the proband and his mother in whom significant elevations occurred. The maternal value was intermediate between those of the proband and normals. An uncle and grandmother were the only other maternal relatives available for study, and their K, (PEP) values were normal. Optimal PK activities, defined by kinetic curve plateaus, were unequivocally normal only in the paternal grandfather and maternal grandmother. All members of the immediate family displayed V,,, values lowered into the range associated with classical heterozygous PK deficiency, i.e. c 50% of mean normal activity. Values which were marginally low were obtained on specimens from the paternal aunt and grandmother, but these two subjects were more convincingly deficient when compared with normal control specimens shipped and processed simultaneously. Erythrocyte PK kinetic curves for PEP were redetermined with ADP concentration
10 660 D. E. Paglia, W. N. Valentine and D. L. Rucknagel TABLE 111. Maximum PK reaction velocities and Michaelis constants for phosphoenolpyruvate Subject Proband (111-2) (mean of five) Mother (11-3) Father (II-2) Brother (111-I) Paternal aunt (11-1) Maternal uncle (11-4) Maternal grandmother (1-4) Paternal grandmother (1-2) Paternal grandfather (1-1) Shipped controls (mean of six) Normal controls (mean of 29) Standard deviation FDP activated I.6 I S FDP activated w elevated to 1.0 m ~ Both. V,,, and K, (PEP) values were uniformly elevated to almost twice those obtained using 0.4 nm ADP, but the distinctions among proband, kindred and normals remained unaltered. Fructose-1,6-diphosphate Efect on Pyruvate Kinase Kinetics As shown in Fig 5, addition of 0.1 mm FDP to the reaction system enhanced the activity of normal PK most prominently when PEP availability was restricted. This occurs whether FIG 5. Effect of fructose-i,6-disphosphate activation on PK kinetics. Broken curves were derived from identical haernolysates assayed simultaneously in the presence of 0.1 m~ FDP. Arrows denote points of half maximal PK activity and K,,, (PEP).
11 Erythrocyte Pyruvate Kinase Defect the red cells under study are obtained from normal controls or from subjects with classical homozygous or heterozygous PK deficiency. Activation by FDP is less pronounced at higher PEP concentrations, thereby elevating V,,, only slightly (10-1 5%). The resultant kinetic effect is to decrease K, (PEP) by t 50% (Table 111). PK in haemolysates from all subjects studied conformed to this expected pattern of kinetic behaviour, except in those from the proband and perhaps his mother as well. In the presence of FDP, proband V,,, increased more appreciably (70%), and K, (PEP) was reduced by 50% but remained distinctly abnormal ( ~). Maternal PK V,,, increased almost 25%, and K;, (PEP) decreased to an intermediate value of 0.19 m. Erythrocyte Pyruvate Kinase Kinetics for Adenosine Diphosphate No abnormalities of K, (ADP) were found, but distinctions between normal and kindred V,,, values were accentuated when ADP served as the variable substrate (Table IV). Compared with means of normal controls assayed simultaneously, parental V,,, was lowered to TABLE IV. Maximum PK reaction velocities and Michaelis constants for adenosine diphosphate 66 I Si I bject Vma, (4 FDP activated Proband (111-2) Mother (11-3) Father (11-2) Shipped controls (mean of four) I r I about one-half and that of the proband to one-fourth. Differences in FDP effect on V,,, were also amplified. Normal PK activity was increased only slightly in the presence of the activator, whereas proband PK activity virtually doubled. Activation of maternal PK was again intermediate in degree. FDP had no appreciable effect on K, (ADP) for any of the subjects studied. DISCUSSION Whether considered from a clinical or a molecular viewpoint, it has become progressively more certain that PK deficiency anaemias encompass a heterogeneous group of inherited defects. Phenotypic expression has been noted to vary considerably among different families and also among affected persons within the same family (Tanaka & Valentine, 1968). The cases reported by Zuelzer et al (1968) were especially notable in this regard, with severely affected propositi and clinically normal relatives all demonstrating comparable levels of PK activity compatible with homozygous deficiency. A broad spectrum of expression has been noted not only for clinical severity but also for biochemical characteristics such as intracellular ATP, ATP stabilities, glycolytic intermediates, NAD/NADH ratios, glucose consumption, and lactate production (Keitt, 1966). The present case is typical of an expanding group which exhibits virtually all the clinical
12 662 D. E. Paglia, W. N. Valentine and D. L. Rucknagel and laboratory features commonly associated with homozygous PK deficiency except for the critical finding of normal or intermediately depressed PK activity on biochemical assay. Specifically, the patient had a lifelong history of chronic haemolytic anaemia and splenomegaly without evidence of spherocytosis, antiglobulin reactions, or haemoglobinopathies. Erythrocyte osmotic fragility was normal, but autohaemolysis was elevated in a manner conforming to the Type 11 category of Selwyn & Dacie (1954). Increased concentrations of glycolytic intermediates were typical of those commonly found in erythrocytes with defective PK catalysis, as were reductions in cellular ATP and concomitant increases in ADP. Further, erythrocyte PK activities in both parents and several relatives were approximately half normal. 3II 2 FIG 6. Genealogy of kindred C. The proband is marked by an arrow. Males and females are indicated by squares and circles, respectively. Heterozygosity for quantitative PK deficiency of the usual type is noted by partially blackened symbols. Shading indicates heterozygosity for the mutant allele. The maternal grandfather (1-3) is deceased and only presumed to be a heterozygote for the mutant isoenzyme. Despite these similarities to quantitative PK deficiency anaemia, assays of proband haemolysates failed to reveal activity reductions sufficient in magnitude to support the diagnosis. Instead of expected depressions to c 10% of normal mean activities, proband V,,, values more closely approximated 40%. Kinetic studies, however, established the unique nature of PK in proband erythrocytes, revealing markedly impaired catalysis when PEP was progressively diluted. The Michaelis constant for this substrate was elevated to five times the normal mean value. Kinetics for the other substrate, ADP, were unaltered, suggesting that the mutational change in the enzyme affected only the PEP binding site. PEP kinetics intermediate between normal and proband were demonstrable in the mother, whereas the father and all other relatives studied appeared entirely normal on this basis. These findings were consistent with the presence of two distinct genes for erythrocyte PK in this family. Paternal relatives were affected with heterozygous PK deficiency of the usual quantitative type with half normal V,,, values and totally normal kinetics, a defect identifiable in three generations (Fig 6). The mother (and presumably the deceased maternal grandfather) had PK characteristics suggestive of heterozygosity for normal PK and the mutant isoenzyme: moderately elevated K, (PEP) and slightly reduced V,,,.
13 Erythrocyte Pyruvate Kinase Defect 663 The PK complement of proband cells was apparently limited in large measure to the mutant isoenzyme, characterized by markedly elevated &, (PEP) and moderately reduced V,,,. This is assumed to result from simultaneous inheritance of the paternal gene determinant of quantitative deficiency and the mutant maternal allele. The ultimate effect, induction of premature haemolysis, seems most likely to be a consequence of ineffective catalysis by the mutant isoenzyme at the low PEP concentrations usually prevalent within erythrocytes. Phenotypic expression is thus identical with that which results from severe quantitative decreases in normal enzyme, since both essentially produce the same perturbation in glycolysis and impairment of ATP regeneration. We are unaware of reported instances of PK isoenzymes which were clearly identical with that in the present case and presume that this simply represents one more example of molecular polymorphism characteristic of this erythroenzymopathy. Several mutant forms have now been identified which vary significantly in their kinetics and responses to FDP activation and additionally in such properties as ph optima, stabilities, and electrophoretic mobilities (Tanaka & Paglia, 1971). Several cases have exhibited comparable increases in K, (PEP), but, in contrast to the present case, concomitant increases in V,,, were also observed when much higher PEP concentrations were employed (Paglia et al, 1968; Tanaka, 1969; Ohyama et a!, 1969; Boivin et al, 1969). Additionally distinctive, FDP activation in two of these families did not significantly affect V,,,, but converted K, (PEP) to virtually normal values (Tanaka, 1969; Paglia & Valentine, 1971). In another family recently restudied by Munro & Miller (1970) the kinetic anomaly was exaggerated by FDP activation, and reaction rates were a dependent variable of PEP concentration over such a broad range that satisfactory measurements of V,,, were not possible in the presence of the activator. The peculiarities of the latter observations may have been partially an effect of enzyme purification procedures, since these are known to alter kinetic and reaction characteristics for erythrocyte PK in some instances (Wiesmann & Tonz, 1966; Boivin & Galand, 1968). Perhaps more comparable to the present case are those reported by Waller & Lohr (1964) and by Lohr et a1 (1968). In the former, K, (PEP) was noted to be two to four times greater than normal in two cases, but V,,, was less than 10% of normal mean. The family in the latter study was found to have a similar elevation in K, (PEP), but the affected proband had a V,,, approximating 40% of normal. Electrophoretic variations were also noted, but FDP activation analyses were not performed. Mentzer & Alpers (1971) have also studied cases of elevated K, (PEP) partially corrected by FDP and coexisting with either normal or decreased PK activities, but details of these investigations are not yet available. Much of the difficulty in deciding which of all these cases represent truly distinct isoenzymes, and which may be identical, is due to considerable variation in assay techniques. While many investigators have employed crude haemolysates in their studies, others have used preparations partially purified by a variety of methods, and it is apparent that purification procedures in themselves can variably alter kinetic qualities of erythrocyte PK. Nonetheless, it is clear that diverse mutant forms of this enzyme do exist, and, since they all accompany a common clinical syndrome, they provide strong evidence to support a basic pathophysiologic role for glycolytic enzymopathies in the induction of premature haemolysis.
14 664 D. E. Paglia, W. N. Valeittine and D. L. Riicknagel ACKNOWLEDGMENTS These studies were supported in part by grants from the United States Public Health Service, the Veterans Administration, and the Leukemia Research Foundation of Los Angeles. The patients were kindly referred by Dr Ruth M. Heyn and Dr Mary Ann Roloff of the Department of Pediatrics, University of Michigan Medical School. The authors are indebted to Klaus Kurschner, Anneliese Merlino, and Ernest0 Guereque for additional technical contributions and to Sharon DeBenedet for assistance with the manuscript. REFERENCES BAUGHAN, M.A., VALENTINB, W.N., PAGLIA, D.E.. WAYS, P.O., SIMONS, E.R. & DEMARSH, Q.B. (1968) Hereditary hemolytic anemia associated with glucosephosphate isomerase (GPI) deficiency-a new enzyme defect of human erythrocytes. Blood, 32, 236. BOMN, P. & GALAND, C. (1968) Recherche d une anomalie moltculaire lors des dtficits en pyruvate kinase Lrythrocytaire. Nouvelle Revue FranGaise d Hthatologie, 8, 201. BOIVIN, P., GALAND, C., MALLARME, J. & PERROT, R. (1969) Mise en tvidence d un enzyme a cinttique anormale dans deus nouveaux cas de d6ficit en pyruvate-kinase trythrocytaire. Pathologie et Biologie, 17, 597. BUCHER, T. & PFLEIDERER, G. (1955) Pyruvate kinase from muscle. Methods in Enzymology (Ed. by S. P. Colowick and N. 0. Kaplan), Vol. I, p 435. Academic Press, New York. KEITT, A.S. (1966) Pyruvate kinase deficiency and related disorders of red cell glycolysis. American journal of Medicine, 41, 762. KOUTRAS, G.A., HAITORI, M., SCHNEIDER, A.S., EBAUGH, F.G., JR & VALENTINE, W.N. (1964) Studies on chromated erythrocytes. Effect of sodium chromate on erythrocyte glutathione reductase. Journal of Clinical Investigation, 43, 323. KRIMSKY, I. (1963) ~-2,3-Diphosphoglycerate. Methods of Enzymatic Analysis (Ed. by H.-U. Bergmeyer), p 238. Academic Press, New York. LOHR, G.W., BLUME, K.G., R~~JIGER, H.W., SOKAL, G. & GuLBrs, E. (1968) A new type of pyruvatekinase deficiency of human erythrocytes. (Letter). Lancet, i, 753. MENTZER, W. & ALPERS, J. (1971) Mild anemia with abnormal RBC pyruvate kinase. (Abstract). Clinical Research, 19, 209. MINAKAMI, S., SUZUKI, C., SAITO, T. & YOSHIKAWA, H. (1965) Studies on erythrocyte glycolysis. I. Determination of the glycolytic intermediates in human erythrocytes. Journat of Biochemistry, 58, 543. MUNRO, G.F. & MILLER, D.R. (1970) Mechanism of fructose diphosphate activation of a mutant pyruvate kinase from human red cells. Biochimica et Biophysica Acta, 206, 87. OHYAMA, H., KUMATORI, T., NISHINA, T. & MIWA, S. (1969) Functionally abnormal pyruvate kinase in congenital hemolytic anemia. Acta Haematofogica Japonica, 32, 330. PAGLIA, D.E. & VALENTINE, W.N. (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. Journal of Laboratory and Clinical Medicine, 70, 158. PAGLIA, D.E. & VALENTINE, W.N. (1971) Additional kinetic distinctions between normal pyruvate kinase and a mutant isozyme from human erythrocytes. Correction of the kinetic anomaly by fructose- 1,6-diphosphate. Blood, 37, 311. PAGLIA, D.E., VALENTINE, W.N., BAUGHAN, M.A., MILLER, D.R., REED, C.F. &MCINTYRE, O.R. (1968) An inherited molecular lesion of erythrocyte pyruvate kinase. Identification of a kinetically aberrant isozyme associated with premature hemolysis. Journal of Clinical Investigation, 47, SCHNEIDER, A.S., VALENTINE, W.N., HATTORI, M. &- HEINS, H.L., JR (1965) Hereditary hemolytic anemia with triosephosphate isomerase deficiency. New England Journal of Medicine, 272, 229. SELWYN, J.G. & DACIE, J.V. (1954) Autohemolysis and other changes resulting from the incubation in vitro of red cells from patients with congenital hemolytic anaemia. Blood, TANAKA, K.R. (1969) Pyruvate kinase deficiency hereditary hemolytic anemia. Japanese Journal of Genetics, 44, Suppl. I TANAKA, K.R. & PAGLIA, D.E. (1971) Pyruvate kinase deficiency. Seminars in Hematology, 8, 367. TANAKA, K.R. & VALENTINE, W.N. (1968) Pyruvate kinase deficiency. Hereditary Disorders of Erythrocyte Metabolism (Ed. by E. Beutler), p 229. Grune & Stratton, New York. VALBNTINE, W.N., HSIEH, H.-S., PAGLIA, D.E., ANDERSON, H.M., BAUGHAN, M.A., JAFF~, E.R. & GARSON, O.M. (1969) Hereditary hemolytic anemia
15 associated with phosphoglycerate kinase deficiency in erythrocytes and leukocytes. New England Journal of Medicine, 280, 528. V m m, W.N., OSKI, F.A., PAGLIA, D.E., BAUGHAN, M.A., SCHNEIDER, AS. & NAIUAN, J.L. (1967) Hereditary hemolytic anemia with hexokinase deficiency. Role of hexokinase in erythrocyte aging. New England Journal ofmedicine, 276, I. Vm-, W.N., PAGLIA, D.E., NEERHOUT, R.C. & KONRAD, P.N. (1970) Erythrocyte glyoxalase I1 deficiency with coincidental hereditary elliptocytosis. Blood, 36, 797. VALENTINE, W.N. & TANAKA, K.R. (1966) Pyruvate kinase: clinical aspects. Methodc in Enzymology (Ed. by S. P. Colowick, N. 0. Kaplan and W. A. Erythrocyte Pyriivate Kinase DefEct 665 Wood), Vol. IX, p 468. Academic Press, New York. WALL=, H.D. & Lorn, G.W. (1964) Hereditary nonspherocytic enzymopenic hemolytic anemia with pyruvate kinase deficiency. Proc. ZX Congress of the International Society of Hematology, Mexico City, Vol. I, p 257. Universidad Nacional Autbnoma de Miico. WIESMA", U. & TONZ, 0. (1966) Investigations of the kinetics of red cell pyruvate kinase in normal individuals and in a patient with pyruvate kinase deficiency. Nature, 209, 612. ZUELZER, W.W., ROBINSON, A.R. & Hsu, T.H.J. (1968) Erythrocyte pyruvate kinase deficiency in non-spherocytic hemolytic anemia : a system of multiple genetic markers? Blood, 32, 3 3.
Erythrocyte enzyme deficiencies Pyruvate kinase deficiency
J. clin. Path., 27, Suppl. (Roy. Coll. Path.), 8, 128-133 Erythrocyte enzyme deficiencies Pyruvate kinase deficiency E. C. GORDON-SMITH From the Department of Haematology, Royal Postgraduate Medical School,
More informationDeficiencies of Glycolytic Pathway
Deficiencies of Glycolytic Pathway -Mature RBCs have the capacity for a limited number of enzymatic reactions -The mature RBC is completely dependent on glucose as a source of energy. Glucose usually (90%)
More informationErythrocyte Metabolism and Enzyme Defects
CE UPDATE HEMATOLOGY I Karen A. B r o w n, M S, MT(ASCP) Erythrocyte Metabolism and Enzyme Defects Red blood cells circulate for approximately 120 days without nuclei or cytoplasmic organelles. Components
More informationStudies on Erythrocyte Glycolysis. Free Energy Changes and Rate Limitings Steps in Erythrocyte Glycolysis*,**
The Journal of Biochemistry, Vol. 59, No. 2, 1966 II. Studies on Erythrocyte Glycolysis Free Energy Changes and Rate Limitings Steps in Erythrocyte Glycolysis*,** By SHIGEKI MINAKAMI and HARUHISA YOSHIKAWA
More informationEnzymatic Assay of PYRUVATE KINASE (EC ) From Rabbit Liver
Enzymatic Assay of PYRUVATE KINASE PRINCIPLE: Phospho(enol)pyruvate + ADP Pyruvate Kinase > Pyruvate + ATP Mg2 + Pyruvate + ß-NADH Lactic Dehydrogenase > Lactate + ß-NAD Abbreviations used: ADP = Adenosine
More informationRegulation of glycolysis/fructolysis in buffalo
Regulation of glycolysis/fructolysis in buffalo spermatozoa K. K. Gandhi and S. R. Anand National Dairy Research Institute, Karnal-132001, India Summary. Assay of maximal activities of 11 glycolytic enzymes
More informationBiochemical Mechanisms of Red Blood Cell 2,3-Di p hosp hog lycerate Increase at High Altitude
AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY 53:ll-18 (1980) Biochemical Mechanisms of Red Blood Cell 2,3-Di p hosp hog lycerate Increase at High Altitude LORNA GRINDLAY MOORE AND GEORGE J. BREWER* Departments
More informationMannose Metabolism in the Human Erythrocyte
Mannose Metabolism in the Human Erythrocyte ERNEST BEUTLER and LESLIE TEEPLE From the City of Hope Medical Center, Duarte, California 911 A B S T R A C T The metabolism of mannose by human erythrocytes
More informationChapter 15 Glycolysis and The Pentose Phosphate Pathway
Principles of Biochemistry Fourth Edition Donald Voet Judith G. Voet harlotte W. Pratt hapter 15 Glycolysis and The Pentose Phosphate Pathway Page No. 47-490 Introduction Glucose: is major source of metabolic
More informationwith their viability and resistance to hemolysis ,19
A n n a l s o f C l i n i c a l L a b o r a t o r y S c i e n c e, V o l. 1, N o. 2 C o p y r i g h t 1 9 7 1, I n s t i t u t e f o r C l i n i c a l S c i e n c e In Vitro Parameters of the Integrity
More informationRed Cell Enzymopathies in the Newborn II. Inherited Deficiencies of Red Cell Enzymes*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 12, No. 3 Copyright 1982, Institute for Clinical Science, Inc. Red Cell Enzymopathies in the Newborn II. Inherited Deficiencies of Red Cell Enzymes* SUSAN
More informationZeina Al-Assaf. Mustafa Khader. Nayef Karadsheh
6 Zeina Al-Assaf Mustafa Khader Nayef Karadsheh 1 P a g e Metabolism in mature erythrocytes: During the maturation of RBCs most of its intracellular organelles are lost such as the nucleus and the mitochondria,
More informationRUBISCO > 2 moles of 3-phosphoglycerate Mg +2
PRINCIPLE: RuDP + CO 2 RUBISCO > 2 moles of 3-phosphoglycerate Mg +2 3-Phosphoglycerate + ATP PGK > Glycerate 1,3-Diphosphate + ADP Glycerate 1,3-Diphosphate + ß-NADH GAPDH > Glyceraldehyde 3-Phosphate
More information0.40. Biochemistry of Carbohydrates
0.40 Biochemistry of Carbohydrates Biochemistry of Carbohydrates ATP ADP Glycolysis The Breakdown of Glucose Primary Energy Source of Cells Central Metabolic Pathway All Reactions Occur in Cytoplasm Two
More informationEnzymatic Assay of CREATININASE (EC ) From Pseudomonas species
PRINCIPLE: Creatinine + H 2 O Creatininase > Creatine Creatine + ATP CPK > Creatine-P + ADP ADP + PEP PK > ATP + Pyruvate Pyruvate + ß-NADH LDH > L-Lactate + ß-NAD Abbreviations used: ATP = Adenosine 5'-Triphosphate
More informationGLYCOLYSIS Generation of ATP from Metabolic Fuels
GLYCOLYSIS Generation of ATP from Metabolic Fuels - Catabolic process degradative pathway - Energy stored in sugars (carbohydrates) released to perform biological work - Transforms GLUCOSE to PYRUVATE
More informationDana Alsulaibi. - Ahmad Almuhtaseb. - Tariq Al - Adaily
- 2 - Dana Alsulaibi - Ahmad Almuhtaseb - Tariq Al - Adaily This sheet will talk about 4 diseases that cause hemolytic anemia, best of luck! 1) Hereditary Spherocytosis Transferred through inheritance
More informationEnzymatic Assay of PHOSPHODIESTERASE, 3':5'-CYCLIC NUCLEOTIDE Crude Complex
PRINCIPLE: 3':5'-cAMP + H 2 O PDE-3':5'-CN > AMP AMP + ATP Myokinase > 2 ADP 2 ADP + 2 PEP Pyruvate Kinase > 2 ATP + 2 Pyruvate 2 Pyruvate + 2 ß-NADH Lactic Dehydrogenase > 2 Lactate + 2 ß-NAD Abbreviations
More informationGlucose is the only source of energy in red blood cells. Under starvation conditions ketone bodies become a source of energy for the brain
Glycolysis 4 / The Text :- Some Points About Glucose Glucose is very soluble source of quick and ready energy. It is a relatively stable and easily transported. In mammals, the brain uses only glucose
More informationEnzymatic Assay of CHOLINE KINASE (EC )
Enzymatic Assay of CHOLINE KINASE PRINCIPLE: Choline + ATP CK > o-phosphocholine + ADP ADP + PEP PK > ATP + Pyruvate Pyruvate + ß-NADH LDH > Lactate + ß-NAD Abbreviations used: ATP = Adenosine 5'-Triphosphate
More informationAnaemia due to a red blood cell membrane defect
Anaemia due to a red blood cell membrane defect BHS training course 2013 1 Red blood cell membrane defect Pathologies Clinical signs Diagnostic criteria Treatment (HS) 2 The pathologies Structural organisation
More informationMBioS 303 Recitation Introductory Biochemistry, Summer 2008 Practice Problem Set #7: General Metabolism Concepts, Glycolysis and the TCA Cycle
MBioS 303 Recitation Introductory Biochemistry, Summer 2008 Practice Problem Set #7: General Metabolism Concepts, Glycolysis and the TCA Cycle (1) Glucose 1-pohsphate is converted to fructose 6-phosphate
More informationIj\.cute intravascular hemolysis in the black rhinoceros: II Erythrocyte enzymes and metabolic intermediates
> j\.cute intravascular hemolysis in the black rhinoceros: Erythrocyte enzymes and metabolic intermediates Donald E. Paglia, MD; William N. Valentine, MD; R. Eric Miller, DVM; Misae Nakatani, BS; i' Richard
More informationAnswer three from questions 5, 6, 7, 8, and 9.
BCH 4053 May 1, 2003 FINAL EXAM NAME There are 9 pages and 9 questions on the exam. nly five are to be answered, each worth 20 points. Answer two from questions 1, 2, 3, and 4 Answer three from questions
More informationHematology Unit Lab 1 Review Material
Hematology Unit Lab 1 Review Material - 2018 Objectives Laboratory instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided
More informationPediatrics. Pyruvate Kinase Deficiency (PKD) Symptoms and Treatment. Definition. Epidemiology of Pyruvate Kinase Deficiency.
Pediatrics Pyruvate Kinase Deficiency (PKD) Symptoms and Treatment See online here Pyruvate kinase deficiency is an inherited metabolic disorder characterized by a deficiency in the enzyme "pyruvate kinase"
More informationRole of Free Radical Reactions in Myelodysplastic Syndrome. Hitoshi IMANISHI,1,* Shinichi MISAWA,1 Tatsuro and Tatsuo ABE 2
J. Clin. Biochem. Nutr., 5, 75-79, 1988 Role of Free Radical Reactions in Myelodysplastic Syndrome Hitoshi IMANISHI,1,* Shinichi MISAWA,1 Tatsuro and Tatsuo ABE 2 TAKINO,1 1Third Department of Internal
More informationGlycolysis by Human Spermatozoa: Levels of Glycolytic Intermediates
BIOLOGY OF REPRODUCrION 5, 221-227 (1971) Glycolysis by Human Spermatozoa: Levels of Glycolytic Intermediates R. N. PETERSON AND M. FREUND Laboratory of Reproductive Pharmacology, Departments of Pharmacology
More informationBiochemistry: A Short Course
Tymoczko Berg Stryer Biochemistry: A Short Course Second Edition CHAPTER 16 Glycolysis 2013 W. H. Freeman and Company Chapter 16 Outline Why is glucose such a prominent fuel in all life forms? 1. Glucose
More informationGlycolysis. Color index: Doctors slides Notes and explanations Extra information Highlights. Biochemistry Team 437
Glycolysis Color index: Doctors slides Notes and explanations Extra information Highlights Biochemistry Team 437 ﺑ ﺳ م ﷲ اﻟرﺣﻣن اﻟرﺣﯾم Objectives: Recognize glycolysis as the major oxidative pathway of
More informationEnzymatic Assay of FRUCTOSE-6-PHOSPHATE KINASE, PYROPHOSPHATE DEPENDENT (EC ) from Mung Bean
PRINCIPLE: PP i + F-6-P PP i -PFK > F-1,6-DP + P i F-2,6-DP 1 F-1,6-DP Aldolase > GAP + DHAP GAP TPI > DHAP 2DHAP + 2 ß-NADH GDH > 2 Glycerol-3-Phosphate + 2 ß-NAD Abbreviations used: PP i = Pyrophosphate
More informationErythrocytes. Dr. MOHAMED SAAD DAOUD BCH 471 1
Red blood cells Erythrocytes Circulating erythrocytes are derived from erythropoietic cells (the precursors of erythrocytes). RBCs arise from mesenchymal cells present in bone marrow. RBCs lack nucleus
More informationBCH 4054 Chapter 19 Lecture Notes
BCH 4054 Chapter 19 Lecture Notes 1 Chapter 19 Glycolysis 2 aka = also known as verview of Glycolysis aka The Embden-Meyerhoff Pathway First pathway discovered Common to almost all living cells ccurs in
More informationHereditary Hemolytic Anemias Associated with Specific Erytbrocyte Enzymopathies
Medical Progress Hereditary Hemolytic Anemias Associated with Specific Erytbrocyte Enzymopathies WILLIAM N. VALENTINE, M.D., Los Angeles IT IS INCREASINGLY apparent that the hereditary hemolytic anemias
More informationHuman Erythrocyte Hexokinase Deficiency
Human Erythrocyte Hexokinase Deficiency CHARACTERIZATION OF A MUTANT ENZYME WITH ABNORMAL REGULATORY PROPERTIES GERT RIJKSEN and GERARD E. J. STAAL, Unit of Medical Enzymology, Haematological Department,
More informationPrevalence of Pyruvate Kinase Deficiency among the Newborns (Shiraz-Iran)
IJBC 2007; 3: 89-93 ORIGINAL ARTICLE Prevalence of Pyruvate Kinase Deficiency among the Newborns (Shiraz-Iran) Majid Yavarian 1, Mozhgan Shahian 2, Mehran Karimi 1, Narges Rezaie 1 1. Hematology Research
More informationManagement. (By the World Health Organization according to the magnitude of the enzyme deficiency and the severity of hemolysis)
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency Management Definition: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an inherited disorder caused by a genetic defect in the red blood cell
More informationCHAPTER 1 The energy-less red blood cell is lost. General introduction and outline of the. thesis
CHAPTER 1 The energy-less red blood cell is lost General introduction and outline of the thesis 9 The energy-less red blood cell is lost The moment the mature red blood cell leaves the bone marrow, it
More informationA GLUCOSEPHOSPHATE ISOMERASE INHIBITOR OF SEASONAL OCCURRENCE IN COD (GADUS MORHUA) AND OTHER FISH
J. mar. biol. Ass. U.K. (969) 49, 447-453 447 Printed in Great Britain A GLUCOSEPHOSPHATE ISOMERASE INHIBITOR OF SEASONAL OCCURRENCE IN COD (GADUS MORHUA) AND OTHER FISH By P. R. DANDO The Plymouth Laboratory
More informationPreservation of metabolic activity in lyophilized human erythrocytes (lyophilization/pentose phosphate shunt/methemoglobin/glycolytic enzymes)
Proc. Nati. Acad. Sci. USA Vol. 89, pp. %7-971, February 1992 Medical Sciences Preservation of metabolic activity in lyophilized human erythrocytes (lyophilization/pentose phosphate shunt/methemoglobin/glycolytic
More informationGlutathione Peroxidase Assay Kit
Glutathione Peroxidase Assay Kit Catalog Number KA0882 100 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 General Information... 4
More informationGlycolysis. Degradation of Glucose to yield pyruvate
Glycolysis Degradation of Glucose to yield pyruvate After this Lecture you will be able to answer: For each step of glycolysis: How does it occur? Why does it occur? Is it Regulated? How? What are the
More informationFate of glucose in living systems. Glycolysis: Derived from Greek words; Glucose + 6O 2 = 6CO 2 + 6H 2 O δg o = kj/mol
Glycolysis: Derived from Greek words; Glykys = Sweet, Lysis = splitting During this process one molecule of glucose (6 carbon molecule) is degraded into two molecules of pyruvate (three carbon molecule).
More informationPFK Activity Assay Kit (Colorimetric)
PFK Activity Assay Kit (Colorimetric) Catalog Number KA3761 100 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 General Information...
More informationBiochemistry of carbohydrates
Biochemistry of carbohydrates الفريق الطبي األكاديمي Done By: - Hanan Jamal لكية الطب البرشي البلقاء التطبيقية / املركز 6166 6102/ In the last lecture we talked about Pyruvate, pyruvate is a central intermediate;
More informationABO INCOMPATIBILITY AND HAEMOLYTIC DISEASE
ABO INCOMPATIBILITY AND HAEMOLYTIC DISEASE OF THE NEWBORN BY G. H. VALENTINE From the St. Thomas Elgin General Hospital, St. Thomas. Ontario, Canada (RECEIVED FOR PUBLICATION NOVEMBER 5, 1957) Since the
More informationChapter 13 Carbohydrate Metabolism
Chapter 13 Carbohydrate Metabolism Metabolism of Foods Food is broken down into carbohydrates, lipids, and proteins and sent through catabolic pathways to produce energy. Glycolysis glucose 2 P i 2 ADP
More informationControl of Glycolysis in the Human Red Blood Cell*
THE JOURNAL OP B~oxuxx~ CHPMI~TRY Vol. 241, No. 21, Issue of November 10, PP. 48484854, 1966 Printed in U.S.A. Control of Glycolysis in the Human Red Blood Cell* (Received for publication, April 22, 1966)
More informationNumerous red cell enzyme disorders have been identified over the past few decades.
CHAPTER 1 INTRODUCTION Numerous red cell enzyme disorders have been identified over the past few decades. However, very few diagnostic tests are routinely performed for these disorders due to technical
More informationEnzymatic Assay of GUANYLATE KINASE (EC )
PRINCIPLE: GMP + ATP Guanylate Kinase > GDP + ADP ADP + PEP Pyruvate Kinase > ATP + Pyruvate GDP + PEP Pyruvate Kinase > GTP + Pyruvate 2 Pyruvate + 2 ß-NADH Lactic Dehydrogenase > 2 Lactate + 2 ß-NAD
More informationSURVIVAL AFTER TRANSFUSION OF Rh-POSITIVE ERYTHROCYTES PREVIOUSLY INCUBATED
J. clin. Path. (1949), 2, 109 SURVIVAL AFTER TRANSFUSION OF Rh-POSITIVE ERYTHROCYTES PREVIOUSLY INCUBATED WITH Rh ANTIBODY BY P. L. MOLLISON From the Medical Research Council Blood Transfusion Research
More informationMetabolic Pathways and Energy Metabolism
Metabolic Pathways and Energy Metabolism Last Week Energy Metabolism - The first thing a living organism has got to be able to do is harness energy from the environment - Plants do it by absorbing sunlight
More informationHEMOLYTIC ANEMIA Anemia of increased destruction Normochromic, normochromic anemia Shortened RBC survival Reticulocytosis - Response to increased RBC
HEMOLYTIC ANEMIAS Edited by: GR. Bahoush, MD. HEMOLYTIC ANEMIA Anemia of increased destruction Normochromic, normochromic anemia Shortened RBC survival Reticulocytosis - Response to increased RBC destruction
More informationRed Blood Cell s Metabolism: HMP Pathway
Click to edit Master title style Edit Master text styles Second level Third level Fourth level Fifth level Red Blood Cell s Metabolism: HMP Pathway Prof. Samar Kassim Prof. Reem Sallam 2017-2018 1. Recognize
More informationCELLULAR RESPIRATION SUMMARY EQUATION. C 6 H 12 O 6 + O 2 6CO2 + 6H 2 O + energy (ATP) STEPWISE REDOX REACTION
CELLULAR RESPIRATION SUMMARY EQUATION C 6 H 12 O 6 + O 2 6CO2 + 6H 2 O + energy (ATP) STEPWISE REDOX REACTION Oxidation: partial or complete loss of electrons Reduction: partial or complete gain of electrons
More informationGlycolysis. BCH 340 lecture 3 Chapter 8 in Lippincott 5 th edition
Glycolysis B 40 lecture hapter 8 in Lippincott 5 th edition All carbohydrates to be catabolized must enter the glycolytic pathway Glycolysis is degradation of glucose to generate energy (ATP) and to provide
More informationANSC 689 PHYSIOLOGICAL CHEMISTRY OF LIVESTOCK SPECIDS. Enzyme Kinetics and Control Reactions
Handout Enzyme Kinetics and Control Reactions ANSC 689 PHYSIOLOGICAL CHEMISTRY OF LIVESTOCK SPECIDS Enzyme Kinetics and Control Reactions I. Kinetics A. Reaction rates 1. First order (reaction rate is
More informationGENETIC CONTROL OF GLYCOLYSIS IN HUMAN ERYTHROCYTES
GENETIC CONTROL OF GLYCOLYSIS IN HUMAN ERYTHROCYTES THOMAS E. GILROY,* GEORGE J. BREWER AND CHARLES F. SING Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan 48109
More informationFIRST BIOCHEMISTRY EXAM Tuesday 25/10/ MCQs. Location : 102, 105, 106, 301, 302
FIRST BIOCHEMISTRY EXAM Tuesday 25/10/2016 10-11 40 MCQs. Location : 102, 105, 106, 301, 302 The Behavior of Proteins: Enzymes, Mechanisms, and Control General theory of enzyme action, by Leonor Michaelis
More informationTIGAR's promiscuity Bolaños, Juan P.
TIGAR's promiscuity Bolaños, Juan P. TIGAR [TP53 (tumour protein 53)-induced glycolysis and apoptosis regulator] is an important survival factor for cancer cells. The enzymatic activity supported by sequence
More informationPart III => METABOLISM and ENERGY. 3.2 Glucose Catabolism 3.2a Glycolysis Pathway 3.2b Glycolysis Regulation 3.2c Fermentation
Part III => METABOLISM and ENERGY 3.2 Glucose Catabolism 3.2a Glycolysis Pathway 3.2b Glycolysis Regulation 3.2c Fermentation Section 3.2a: Glycolysis Synopsis 3.2a - Dietary starch (eg bread, rice and
More informationEnzymatic Assay of PHOSPHORYLASE KINASE (EC )
PRINCIPLE: Enzymatic Assay of PHOSPHORYLASE KINASE 2 Phosphorylase b + 4 ATP Phosphorylase Kinase > Phosphorylase a + 4 ADP Glycogen n + P i Phosphorylase a > Glycogen n-1 + a-d-glucose 1-Phosphate a-d-glucose
More informationHematology Revision. By Dr.AboRashad . Mob
1 1- Hb A2 is consisting of: a) 3 ά chains and 2 γ chains b) 2 ά chains and 2 β chains c) 2 ά chains and 2 δ chains** d) 2 ά chains and 3 δ chains e) 3 ά chains and 2 δ chains 2- The main (most) Hb found
More informationCHAPTER 16. Glycolysis
CHAPTER 16 Glycolysis Net reaction of Glycolysis Converts: 1 Glucose Hexose stage 2 pyruvate - Two molecules of ATP are produced - Two molecules of NAD + are reduced to NADH Triose stage Glucose + 2 ADP
More informationPRINT your Name Student (FAMILY, first name) Midterm 7:00 P.M.
PRINT your Name Student No. (FAMILY, first name) BIOCHEMISTRY 311A VERSION 1 (ONE) Midterm 7:00 P.M. Examiners: Dr. R. E. MacKenzie (69%) Dr. A. Storer (18%) Dr. W. Mushynski (13%) READ THE QUESTIONS CAREFULLY!!
More informationGlycolysis Introduction to Metabolism Regulation of Metabolism Overview of Glycolysis Reactions of Glycolysis
Glycolysis Introduction to Metabolism Regulation of Metabolism Overview of Glycolysis Reactions of Glycolysis Suggested Reading: Lippincot s Ilustrated reviews: Biochemistry Glycolysis, an example of metabolic
More informationThis is an example outline of 3 lectures in BSC (Thanks to Dr. Ellington for sharing this information.)
This is an example outline of 3 lectures in BSC 2010. (Thanks to Dr. Ellington for sharing this information.) Topic 10: CELLULAR RESPIRATION (lectures 14-16) OBJECTIVES: 1. Know the basic reactions that
More informationIn glycolysis, glucose is converted to pyruvate. If the pyruvate is reduced to lactate, the pathway does not require O 2 and is called anaerobic
Glycolysis 1 In glycolysis, glucose is converted to pyruvate. If the pyruvate is reduced to lactate, the pathway does not require O 2 and is called anaerobic glycolysis. If this pyruvate is converted instead
More informationNotes CELLULAR RESPIRATION SUMMARY EQUATION C 6 H 12 O 6 + O 2. 6CO 2 + 6H 2 O + energy (ATP) STEPWISE REDOX REACTION
AP BIOLOGY CELLULAR ENERGETICS ACTIVITY #2 Notes NAME DATE HOUR SUMMARY EQUATION CELLULAR RESPIRATION C 6 H 12 O 6 + O 2 6CO 2 + 6H 2 O + energy (ATP) STEPWISE REDOX REACTION Oxidation: partial or complete
More informationCellular Respiration Stage 1: Glycolysis
Cellular Respiration Stage 1: Glycolysis 2007-2008 What s the point? The point is to make! 2007-2008 Glycolysis Breaking down glucose glyco lysis (splitting sugar) glucose pyruvate 6C 2x 3C In the cytosol?
More informationCellular Respiration: Harvesting Chemical Energy
Chapter 9 Cellular Respiration: Harvesting Chemical Energy PowerPoint Lecture Presentations for Biology Eighth Edition Neil Campbell and Jane Reece Lectures by Chris Romero, updated by Erin Barley with
More informationDr. DerVartanian is ill and will likely not be able to give lectures this week.
Dr. DerVartanian is ill and will likely not be able to give lectures this week. Today s slides will be put on-line today, and are designed to introduce you to glycolysis. You should use these slides, along
More informationNo. 9] Posttransfusion Survival of the Stored Red Blood Cells 619
618 [Vol. 36, 147. Posttrans f usion Survival o f the Red Blood Cells Stored in a Medium Containing Adenine and Inosine By Takehisa WADA,*' Fumimaro TAKAKU,*' Kiku NAKAO,*' Makoto NAKAO,**' Toshiko NAKAo,**'
More informationBiology 638 Biochemistry II Exam-1
Biology 638 Biochemistry II Exam-1 Using the following values, answer questions 1-3. ATP + H 2 O ADP + P i ΔG = -30 kj/mol Creatine-phosphate + H 2 O Creatine + P i ΔG = -12 kj/mol ½O 2 + 2H + + 2e - H
More information20X Buffer (Tube1) 96-well microplate (12 strips) 1
PROTOCOL MitoProfile Rapid Microplate Assay Kit for PDH Activity and Quantity (Combines Kit MSP18 & MSP19) 1850 Millrace Drive, Suite 3A Eugene, Oregon 97403 MSP20 Rev.1 DESCRIPTION MitoProfile Rapid Microplate
More informationCHE 242 Exam 3 Practice Questions
CHE 242 Exam 3 Practice Questions Glucose metabolism 1. Below is depicted glucose catabolism. Indicate on the pathways the following: A) which reaction(s) of glycolysis are irreversible B) where energy
More informationBCH 471 Experiment (7) HEMOGIOBIN AND ANEMIA, ERYTHROCYTE SEDIMENTATION RATE (ESR) AND HEMATOCRIT (HCT)
BCH 471 Experiment (7) HEMOGIOBIN AND ANEMIA, ERYTHROCYTE SEDIMENTATION RATE (ESR) AND HEMATOCRIT (HCT) OBJECTIVES 1) Quantitative determination of hemoglobin in a blood sample. 2) Determination of erythrocyte
More informationPentose Phosphate Pathway. Dr. Abir Alghanouchi Biochemistry department Sciences college
Pentose Phosphate Pathway Dr. Abir Alghanouchi Biochemistry department Sciences college The pentose phosphate pathway is an alternate route for the oxidation of glucose where ATP (energy) is neither produced
More informationApproach to Hemolysis
Objectives: Approach to Hemolysis To know the function of platelets and the relationship between the platelet count in peripheral blood and the extent of abnormal bleeding. To know about the diseases associated
More informationBiochemistry. Glycolysis. Metabolism of Carbohydrates. Dr.S.K.Khare, Professor IIT Delhi. Principal Investigator.
Paper : 04 Metabolism of carbohydrates Module :03 Principal Investigator Paper Coordinator Content Reviewer Content Writer Dr.S.K.Khare, Professor IIT Delhi. Dr. Ramesh Kothari, Professor UGC-CAS Department
More informationΒ-FRUCTOFURANOSIDASE ENZYME
KINETICS ANALYSIS OF Β-FRUCTOFURANOSIDASE ENZYME 2-The effects of enzyme concentration on the rate of an enzyme catalyzed reaction. Systematic names and numbers β-fructofuranosidase (EC 3.2.1.26) Reactions
More informationNotes CELLULAR RESPIRATION SUMMARY EQUATION C 6 H 12 O 6 + O 2. 6CO 2 + 6H 2 O + energy (ATP) STEPWISE REDOX REACTION
AP BIOLOGY CELLULAR ENERGETICS ACTIVITY #2 Notes NAME DATE HOUR SUMMARY EQUATION CELLULAR RESPIRATION C 6 H 12 O 6 + O 2 6CO 2 + 6H 2 O + energy (ATP) STEPWISE REDOX REACTION Oxidation: partial or complete
More informationCarbohydrate. Metabolism
Carbohydrate Metabolism Dietary carbohydrates (starch, glycogen, sucrose, lactose Mouth salivary amylase Summary of Carbohydrate Utilization Utilization for energy (glycolysis) ligosaccharides and disaccharides
More informationRegulation of Glucose Metabolism by Adenine Nucleotides in Round Spermatids from Rat Testes*
THE JOURNAL OF Blo~oclcnl. CHEMISTRY Vol. 257, No. 23, Issue of December 10, pp. 13945-13950, I982 Printed in U.S. A. Regulation of Glucose Metabolism by Adenine Nucleotides in Round Spermatids from Rat
More informationDr. Shiva Nazari Assistant Professor of Pediatric Oncologist & Hematologist Shahid Beheshti Medical Science University Mofid Children s Hospital
Dr. Shiva Nazari Assistant Professor of Pediatric Oncologist & Hematologist Shahid Beheshti Medical Science University Mofid Children s Hospital Reduction in the normal red cell survival (120 days) RBC
More informationPyruvate Kinase of Streptococcus lactis
JOURNAL OF BACTERIOLOGY, OCt. 1974, p. 52-58 Vol. 120, No. 1 Copyright 0 1974 American Society for Microbiology Printed in U.S.A. Pyruvate Kinase of Streptococcus lactis LOUISE B. COLLINS AND TERENCE D.
More information2. (12 pts) Given the following metabolic pathway (as it occurs in the cell):
Answer Sheet 1 (Gold) 1. (1 pt) Write your exam ID (A) in the blank at the upper right of your answer sheet. 2. (12 pts) Given the following metabolic pathway (as it occurs in the cell): a. Would you expect
More informationThe effect of chlorpromazine on cerebral glucose, ATP, ADP, AMP and ATPase in the mouse
Br. J. Pharmac. (1968), 34, 70-75. The effect of chlorpromazine on cerebral glucose, ATP, ADP, AMP and ATPase in the mouse A. K. CHOWDHURY, ANNETTE SKINNER, R. G. SPECTOR AND S.-L. YAP Department of Pharmacology,
More informationCellular Respiration Stage 1: (Glycolysis) AP Biology
Cellular Respiration Stage 1: (Glycolysis) What s the point? The point is to make! Glycolysis: Breaking down glucose glyco lysis (splitting sugar) glucose pyruvate 6C 2x 3C In the cytosol? Why does that
More informationYear 2003 Paper two: Questions supplied by Tricia
QUESTION 65 A 36-year-old man presents in a post-ictal state after an observed generalised seizure. Full blood investigation shows: haemoglobin 0 g/l [128-175] mean corpuscular volume (MCV) 106 fl [80-7]
More informationEnzymatic Assay of RIBOKINASE (EC )
PRINCIPLE: ATP + D-Ribose Ribokinase > ADP + D-Ribose 5-P D-Ribose 5-P PRI > D-Ribulose 5-P D-Ribulose 5-P Ru-5-P-3-Epim > D-Xylulose 5-P D-Xylulose 5-P + D-Ribose 5-P TK Mg++, Cocarboxylase > GAP + Sedoheptulose
More informationHAEMOLYTIC ANAEMIA. Dr. Hasan Fahmawi, MRCP(London), FRCP(Edin) Consultant Physician
HAEMOLYTIC ANAEMIA Dr. Hasan Fahmawi, MRCP(London), FRCP(Edin) Consultant Physician Haemolysis Definition shortening of the normal red blood lifespan of 120 days Increase in unconjugated bilirubin, increased
More informationCoenzyme A is a substrate or a product. (four enzymes) NADH is a substrate or a product. (five enzymes)
BCH 4053 August 4, 2000 Mini-Exam NAME (25) 1. Following is an alphabetical list of the glycolytic and TCA cycle enzymes plus a few other enzymes we have discussed. Choose enzymes from this list that are
More informationD-FRUCTOSE and D-GLUCOSE
www.megazyme.com DFRUCTOSE and DGLUCOSE (Liquid Stable Format) ASSAY PROCEDURE KFRGLQR 02/17 (1100 AutoAnalyser Assays of each per Kit) or (1100 Microplate Assays of each per Kit) Megazyme 2017 INTRODUCTION:
More informationYear 2004 Paper two: Questions supplied by Megan 1
Year 2004 Paper two: Questions supplied by Megan 1 QUESTION 93 A 16yo adolescent male presents with lethargy and lower respiratory tract infection. Physical examination shows him to be febrile, icteric
More informationChapter 10. Regulatory Strategy
Chapter 10 Regulatory Strategy Regulation of enzymatic activity: 1. Allosteric Control. Allosteric proteins have a regulatory site(s) and multiple functional sites Activity of proteins is regulated by
More informationMETABOLISM Biosynthetic Pathways
METABOLISM Biosynthetic Pathways Metabolism Metabolism involves : Catabolic reactions that break down large, complex molecules to provide energy and smaller molecules. Anabolic reactions that use ATP energy
More informationGLUH PRINCIPLE REF B ANNUAL REVIEW Reviewed by. Date. Date INTENDED USE
SYNCHRON System(s) Chemistry Information Sheet Copyright 2014 Beckman Coulter, Inc. GLUH Glucose REF B24985 For In Vitro Diagnostic Use Rx Only ANNUAL REVIEW Reviewed by Date Reviewed by Date PRINCIPLE
More informationChem 109 C. Fall Armen Zakarian Office: Chemistry Bldn 2217
Chem 109 C Fall 2014 Armen Zakarian ffice: Chemistry Bldn 2217 o Catabolism of carbohydrates: 10 reactions of glycolysis Chapter 25 C C 2 C 2 D-glucose α-d-glucopyranose aworth projection α-d-glucopyranose
More informationBIOCHEMISTRY. Glycolysis. by Dr Jaya Vejayan Faculty of Industrial Sciences & Technology
BIOCHEMISTRY Glycolysis by Dr Jaya Vejayan Faculty of Industrial Sciences & Technology email: jayavejayan@ump.edu.my Chapter Description Overview This chapter is related to carbohydrate catabolism. It
More information